台股 » 個股 » 台康生技 » 籌碼相關 » 融資融券與借券

台康生技

(6589)
可現股當沖
  • 股價
    49.70
  • 漲跌
    ▲0.35
  • 漲幅
    +0.71%
  • 成交量
    288張
  • 產業
    上市 生技醫療類股
  • 518人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
台康生技 (6589) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

台康生技 (6589) 融資融券與借券

台康生技 (6589) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
10/21-142,9444.77020000.0749.350.51%232
10/20-82,9584.79020000.0749.10.61%239
10/19322,9664.8020000.0748.8-4.50%494
10/16232,9344.75-120000.0751.12.51%484
10/15-12,9114.71130000.149.85-0.10%349
10/14122,9124.71020000.0749.91.11%431
10/13-252,9004.7020000.0749.35-1.50%422
10/1252,9254.74020000.0750.1-2.34%563
10/08-72,9204.73020000.0751.31.38%414
10/07-182,9274.7402010.170.0750.6-0.59%586
10/06192,9454.77020000.0750.90.39%394
10/0592,9264.74-220000.0750.7-0.20%491
10/02882,9174.72040.01000.1450.8-3.05%801
10/0192,8294.58040.01000.1452.4-1.87%554
09/30-962,8204.57040.01000.1453.43.49%951
09/29-22,9164.72040.01000.1451.60.39%356
09/241192,9184.72040.01000.1451.4-4.64%832
09/2312,7994.53040.01000.1453.93.85%1,185
09/22202,7984.53040.01000.1451.90.39%587
09/21352,7784.5040.01000.1451.7-1.90%525
09/18-52,7434.44040.01000.1552.72.93%1,749
09/17-1132,7484.45140.01000.1551.24.60%1,509
09/16-252,8614.54030000.148.950.62%628
09/15222,8864.58130000.148.651.25%621
09/14-272,8644.54020000.0748.056.07%782
09/11932,8914.59020000.0745.3-5.43%975
09/10322,7984.44020000.0747.9-0.62%388
09/0962,7664.39020000.0748.21.58%313
09/08-12,7604.3802020.410.0747.45-0.11%491
09/07142,7614.38020000.0747.5-1.14%388
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
10/2100002@Limit2001170-1173,45849.350.51%232
10/2000002@Limit200180-183,57549.10.61%239
10/1900002@Limit201830153,59348.8-4.50%494
10/16100-12@Limit2000003,57851.12.51%484
10/1501013@Limit2000003,57849.85-0.10%349
10/1400002@Limit2020023,57849.91.11%431
10/1300002@Limit201514013,57649.35-1.50%422
10/1200002@Limit208210-133,57550.1-2.34%563
10/0800002@Limit209520-433,58851.31.38%414
10/0700002@Limit203800383,63150.6-0.59%586
10/0600002@Limit200980-983,59350.90.39%394
10/05200-22@Limit2013140-13,69150.7-0.20%491
10/0200004@Limit20.0153610-83,69250.8-3.05%801
10/0100004@Limit20.01173010-2843,70052.4-1.87%554
09/3000004@Limit20.0183560-3483,98453.43.49%951
09/2900004@Limit20.01214630-4424,33251.60.39%356
09/2400004@Limit20.01685010-4334,77451.4-4.64%832
09/2300004@Limit20.0151310205,20753.93.85%1,185
09/2200004@Limit20.0152600-2555,18751.90.39%587
09/2100004@Limit20.01511720-1215,44251.7-1.90%525
09/1800004@Limit20.01111310805,56352.72.93%1,749
09/1701014@Limit20.0186870-15,48351.24.60%1,509
09/1600003@Limit20121320-1205,48448.950.62%628
09/1501013@Limit204450395,60448.651.25%621
09/1400002@Limit204990405,56548.056.07%782
09/1100002@Limit20128940345,52545.3-5.43%975
09/1000002@Limit204442025,49147.9-0.62%388
09/0900002@Limit2015300-155,48948.21.58%313
09/0800002@Limit2011590-485,50447.45-0.11%491
09/0700002@Limit207460685,55247.5-1.14%388
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
10/21562,779,5002,778,75024.12-13.39
10/20683,332,8503,340,50028.5112.5
10/191075,275,9005,302,10021.64244.86
10/16995,037,3505,061,70020.44245.96
10/15693,425,7503,437,75019.77173.91
10/141668,192,1008,202,35038.5461.75
10/131004,938,6004,943,95023.6953.5
10/121396,994,6506,999,70024.6936.33
10/08944,789,8004,793,80022.742.55
10/0721210,874,30010,900,50036.2123.58
10/06773,919,7003,925,50019.5775.32
10/051738,780,9008,786,90035.2234.68
10/021487,536,4007,570,30018.48229.05
10/011729,062,6009,072,60031.0458.14
09/30985,143,9005,200,50010.3577.55
09/29683,489,8003,495,90019.1189.71
09/241668,673,4008,663,90019.94-57.23
09/2320910,942,40011,110,40017.63803.83
09/221708,789,5008,828,80028.94231.18
09/21854,409,4004,418,70016.19109.41
09/1833817,352,60017,474,60019.33360.95
09/1729214,594,95014,689,85019.36325
09/161979,721,1009,698,50031.36-114.72
09/151235,949,3506,010,10019.81493.9
09/1421410,007,40010,131,00027.37577.57
09/111607,306,2007,388,95016.41517.19
09/101446,833,3006,846,75037.0993.4
09/09512,440,5502,441,40016.316.67
09/081276,023,3506,036,40025.87102.76
09/071014,817,9504,823,95026.0659.41
台康生技乳癌生物相似藥與日藥廠簽署授權、受惠健保擴大給付雙喜臨門Anue鉅亨-2026/06/30
台康生技持續推進8個生物相似藥產品線 可望帶動授權金與分潤收入Anue鉅亨-2026/06/18
台康生技 相關文章
台康生技 相關影音